These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2228832)

  • 1. 4-Quinolone resistant staphylococci.
    Dryden MS; Ludlam HA; Phillips I
    J Antimicrob Chemother; 1990 Sep; 26(3):448-9. PubMed ID: 2228832
    [No Abstract]   [Full Text] [Related]  

  • 2. Linezolid resistance in coagulase-negative staphylococci.
    Kelly S; Collins J; Davin M; Gowing C; Murphy PG
    J Antimicrob Chemother; 2006 Oct; 58(4):898-9; author reply 899-900. PubMed ID: 16854956
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibacterial activity of quinolones against coagulase-negative staphylococci and the quinolone resistance-determining region of the gyrA genes from six species.
    Takahata M; Yonezawa M; Matsubara N; Watanabe Y; Narita H; Matsunaga T; Igarashi H; Kawahara M; Onodera S; Oishi Y
    J Antimicrob Chemother; 1997 Sep; 40(3):383-6. PubMed ID: 9338491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ciprofloxacin resistance in coagulase-positive and -negative staphylococci: role of mutations at serine 84 in the DNA gyrase A protein of Staphylococcus aureus and Staphylococcus epidermidis.
    Sreedharan S; Peterson LR; Fisher LM
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2151-4. PubMed ID: 1662027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different susceptibility of coagulase-positive and coagulase-negative staphylococci to ciprofloxacin.
    Utili R; Tripodi MF; Rosario P; Andreana A; Locatelli A; Rambaldi A; Florio A
    New Microbiol; 1996 Oct; 19(4):309-14. PubMed ID: 8914131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro selection of quinolone-resistant staphylococcal mutants by a single exposure to ciprofloxacin or trovafloxacin (CP-99,219) -letter-.
    Barry AL; Brown SD; Fuchs PC
    J Antimicrob Chemother; 1996 Aug; 38(2):324-7. PubMed ID: 8877554
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of gas-liquid chromatography for subgrouping coagulase-negative staphylococci during a nosocomial sepsis outbreak.
    Kotilainen P; Huovinen P; Eerola E
    Eur J Clin Microbiol Infect Dis; 1995 May; 14(5):412-20. PubMed ID: 7556230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of levofloxacin against coagulase-positive and -negative staphylococci.
    Cafiso V; Messina C; Santagati M; Campanile F; Bonfiglio G; Stefani S
    Drugs Exp Clin Res; 2001; 27(3):107-11. PubMed ID: 11447768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciprofloxacin-resistant Staphylococcus epidermidis and hands.
    Burnie JP; Loudon KW
    Lancet; 1997 Mar; 349(9052):649. PubMed ID: 9057750
    [No Abstract]   [Full Text] [Related]  

  • 10. Coagulase-negative staphylococci in air samples from operating theatres.
    Kiss L; Sztroj T; Széll M
    Acta Microbiol Immunol Hung; 1996; 43(1):39-46. PubMed ID: 8806942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antistaphylococcal activity of DX-619, a new des-F(6)-quinolone, compared to those of other agents.
    Bogdanovich T; Esel D; Kelly LM; Bozdogan B; Credito K; Lin G; Smith K; Ednie LM; Hoellman DB; Appelbaum PC
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3325-33. PubMed ID: 16048943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinolones in sweat and quinolone resistance.
    Hawkey PM
    Lancet; 1997 Jan; 349(9046):148-9. PubMed ID: 9111534
    [No Abstract]   [Full Text] [Related]  

  • 13. Epidemiology of the colonization of inpatients and outpatients with ciprofloxacin-resistant coagulase-negative staphylococci.
    Kotilainen P; Huovinen S; Järvinen H; Aro H; Huovinen P
    Clin Infect Dis; 1995 Sep; 21(3):685-7. PubMed ID: 8527571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro induction of resistance in coagulase-negative staphylococci to vancomycin and teicoplanin.
    Watanakunakorn C
    J Antimicrob Chemother; 1988 Sep; 22(3):321-4. PubMed ID: 2972670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic resistance of biomaterial-adherent coagulase-negative and coagulase-positive staphylococci.
    Naylor PT; Myrvik QN; Gristina A
    Clin Orthop Relat Res; 1990 Dec; (261):126-33. PubMed ID: 2173986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of levofloxacin, ofloxacin and other quinolones against coagulase-negative staphylococci.
    Foleno BD; Lafredo SC; Fu KP
    Chemotherapy; 1993; 39(2):120-3. PubMed ID: 8458244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The epidemiology of ciprofloxacin resistance in coagulase-negative staphylococci in CAPD patients.
    Dryden MS; Talsania H; McCann M; Cookson BD; Phillips I
    Epidemiol Infect; 1992 Aug; 109(1):97-112. PubMed ID: 1499676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of ciprofloxacin-resistant coagulase-negative staphylococcal skin flora in immunocompromised patients receiving ciprofloxacin.
    Kotilainen P; Nikoskelainen J; Huovinen P
    J Infect Dis; 1990 Jan; 161(1):41-4. PubMed ID: 2295857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the appearance of drug resistance during therapy alter bacterial susceptibility to opsonophagocytosis?
    Gemmell CG
    Drugs Exp Clin Res; 1996; 22(2):51-5. PubMed ID: 8879979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Norfloxacin induced resistance to fluoroquinolones & structurally unrelated antimicrobial agents in coagulase negative staphylococci.
    Deshmukh SR; Nagoba BS; Wadher BJ; Tumane P
    Indian J Med Res; 1997 Nov; 106():461-4. PubMed ID: 9415741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.